Insider Stock Trading History of Smith Sandford D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Smith Sandford D since year 2005. The trader's CIK number is 1243004. At the time of this reporting, Smith Sandford D is the Director of Qlt Inc/bc . (stock ticker symbol QLTI). See this page for all insider trading activities at Qlt Inc/bc .

Note that in the past SMITH SANDFORD D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Smith Sandford D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-01-27 NVLN Qlt Inc/bc Option Ex 456 .00 0
2016-07-27 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,222 .00 0
2016-01-27 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,223 .00 0
2014-10-22 APRI Nexmed Inc Buy 8,300 1.52 12,649
2014-10-23 APRI Nexmed Inc Buy 18,200 1.59 28,992
2013-10-29 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,502 15.00 37,530
2013-10-29 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,502 95.00 237,690
2013-08-12 AEGR Aegerion Pharmaceuticals, Inc. Sale 1,537 92.25 141,791
2013-08-09 AEGR Aegerion Pharmaceuticals, Inc. Sale 8,463 92.33 781,414
2013-08-09 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 10,000 15.64 156,400
2011-04-04 GENZ Genzyme Corp Option Ex 14,500 .00 0
2010-07-23 GENZ Genzyme Corp Option Ex 32,041 43.88 1,405,959
2010-07-23 GENZ Genzyme Corp Sale 32,041 64.53 2,067,701
2010-05-25 GENZ Genzyme Corp Sale 8,887 45.61 405,336
2010-05-22 GENZ Genzyme Corp Option Ex 5,000 .00 0
2010-05-24 GENZ Genzyme Corp Option Ex 15,000 .00 0
2010-05-21 GENZ Genzyme Corp Option Ex 4,750 .00 0
2010-05-24 GENZ Genzyme Corp Sale 1,525 48.93 74,618
2010-03-19 GENZ Genzyme Corp Sale 3,359 58.90 197,845
2009-05-22 GENZ Genzyme Corp Option Ex 5,000 .00 0
2009-05-26 GENZ Genzyme Corp Sale 1,641 56.54 92,785
2008-01-16 GENZ Genzyme Corp Sale 20,181 79.70 1,608,425
2008-01-16 GENZ Genzyme Corp Option Ex 20,181 49.85 1,006,123
2008-01-11 GENZ Genzyme Corp Option Ex 4,719 46.24 218,206
2008-01-11 GENZ Genzyme Corp Sale 4,719 79.70 376,104
2008-01-09 GENZ Genzyme Corp Option Ex 100 46.24 4,624
2008-01-09 GENZ Genzyme Corp Sale 100 79.70 7,970
2007-10-15 GENZ Genzyme Corp Sale 25,000 74.77 1,869,250
2007-10-15 GENZ Genzyme Corp Option Ex 25,000 46.24 1,156,000
2007-10-10 GENZ Genzyme Corp Sale 25,000 69.80 1,745,000
2007-10-10 GENZ Genzyme Corp Option Ex 25,000 45.07 1,126,750
2007-06-20 ARIA Ariad Pharmaceuticals Inc Option Ex 45,000 2.76 124,199
2006-08-31 GENZ Genzyme Corp Option Ex 14,220 32.52 462,434
2006-08-31 GENZ Genzyme Corp Sale 11,145 66.23 738,133
2006-03-01 GENZ Genzyme Corp Option Ex 12,500 43.90 548,750
2006-03-01 GENZ Genzyme Corp Sale 12,500 69.12 864,000
2005-07-29 GENZ Genzyme Corp Sale 1,118 71.72 80,177

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Sandford D (Director of Qlt Inc/bc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.